Half-year report · HY
2413.TEDINET S100X3FS
Period2025-04-01 → 2025-09-30
Filed2025-11-14
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥170.9bn | 2025-04-01 → 2025-09-30 | Cons. | Revenue IFRS |
| Revenue | ¥284.9bn | 2024-04-01 → 2025-03-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥124.8bn | 2024-04-01 → 2024-09-30 | Cons. | Revenue IFRS |
| Operating income | ¥36.0bn | 2025-04-01 → 2025-09-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥29.0bn | 2024-04-01 → 2024-09-30 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥36.7bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥64.8bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥29.1bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥22.7bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥40.5bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥17.3bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥25.3bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss IFRS |
| Net income | ¥19.6bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss IFRS |
| Total assets | ¥612.4bn | at 2025-09-30 | Cons. | Assets IFRS |
| Total assets | ¥581.7bn | at 2025-03-31 | Cons. | Assets IFRS |
| Total assets | ¥491.5bn | at 2024-09-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥188.7bn | at 2025-09-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥168.9bn | at 2025-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥423.7bn | at 2025-09-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥412.8bn | at 2025-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥364.4bn | at 2024-09-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥366.7bn | at 2024-03-31v | Cons. | Equity IFRS |
| Equity (owners) | ¥387.3bn | at 2025-09-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥378.4bn | at 2025-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥349.5bn | at 2024-09-30 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥133.8bn | at 2025-09-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥134.9bn | at 2025-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥148.1bn | at 2024-09-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥149.7bn | at 2024-03-31v | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥36.3bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥51.7bn | 2024-04-01 → 2025-03-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥23.6bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥15.5bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥39.1bn | 2024-04-01 → 2025-03-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥11.3bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | −¥22.2bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥27.2bn | 2024-04-01 → 2025-03-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥12.6bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥33.47 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥59.62 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥25.47 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥33.46 | 2025-04-01 → 2025-09-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥59.6 | 2024-04-01 → 2025-03-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥25.4 | 2024-04-01 → 2024-09-30 | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 63.2% | at 2025-09-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 65.1% | at 2025-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 71.1% | at 2024-09-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 57
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2025-04-01 → 2025-09-30 | −¥2.2bn |
| Reconciling Itemsreconciling | revenue intersegment | 2025-04-01 → 2025-09-30 | −¥2.2bn |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2025-09-30 | −¥804m |
| Career Solutionreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥13.2bn |
| Career Solutionreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥13.1bn |
| Career Solutionreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥38m |
| Career Solutionreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥4.3bn |
| Evidence Solutionreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥12.2bn |
| Evidence Solutionreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥12.1bn |
| Evidence Solutionreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥85m |
| Evidence Solutionreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥2.3bn |
| Medical Platformreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥52.0bn |
| Medical Platformreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥49.9bn |
| Medical Platformreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥2.0bn |
| Medical Platformreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥17.9bn |
| Overseasreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥41.1bn |
| Overseasreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥41.1bn |
| Overseasreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥5m |
| Overseasreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥8.9bn |
| Patient Solutionreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥27.4bn |
| Patient Solutionreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥27.4bn |
| Patient Solutionreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥1.1bn |
| Site Solutionreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥26.3bn |
| Site Solutionreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥26.3bn |
| Site Solutionreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥3m |
| Site Solutionreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥1.7bn |
| —segment total | revenue | 2025-04-01 → 2025-09-30 | ¥172.0bn |
| —segment total | revenue external | 2025-04-01 → 2025-09-30 | ¥169.9bn |
| —segment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥2.2bn |
| —segment total | segment profit | 2025-04-01 → 2025-09-30 | ¥36.2bn |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2024-09-30 | −¥1.9bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2024-09-30 | −¥1.9bn |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥1.7bn |
| Career Solutionreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥11.6bn |
| Career Solutionreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥11.6bn |
| Career Solutionreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥18m |
| Career Solutionreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥4.1bn |
| Evidence Solutionreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥11.9bn |
| Evidence Solutionreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥11.8bn |
| Evidence Solutionreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥100m |
| Evidence Solutionreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥1.9bn |
| Medical Platformreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥42.5bn |
| Medical Platformreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥40.7bn |
| Medical Platformreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥1.7bn |
| Medical Platformreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥14.6bn |
| Overseasreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥38.0bn |
| Overseasreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥38.0bn |
| Overseasreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥28m |
| Overseasreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥6.6bn |
| Site Solutionreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥21.6bn |
| Site Solutionreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥21.6bn |
| Site Solutionreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥6m |
| Site Solutionreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥3.0bn |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥125.6bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥123.7bn |
| —segment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥1.9bn |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥30.3bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 668
| Item | Context | Value | Unit |
|---|---|---|---|
| Purchase of property plant and equipment inv cf IFRS | InterimDuration | -3624000000 | JPY |
| Purchase of investment property inv cf IFRS | Prior1InterimDuration | － | JPY |
| Purchase of investment property inv cf IFRS | InterimDuration | -510000000 | JPY |
| Purchase of intangible assets inv cf IFRS | Prior1InterimDuration | -1122000000 | JPY |
| Purchase of intangible assets inv cf IFRS | InterimDuration | -2326000000 | JPY |
| Payments for leasehold deposits and guarantee deposits inv cf IFRS | Prior1InterimDuration | -195000000 | JPY |
| Payments for leasehold deposits and guarantee deposits inv cf IFRS | InterimDuration | -270000000 | JPY |
| Proceeds from collection of leasehold deposits and guarantee deposits inv cf IFRS | Prior1InterimDuration | 87000000 | JPY |
| Proceeds from collection of leasehold deposits and guarantee deposits inv cf IFRS | InterimDuration | 76000000 | JPY |
| Payments for loans receivable inv cf IFRS | Prior1InterimDuration | -1000000 | JPY |
| Payments for loans receivable inv cf IFRS | InterimDuration | -868000000 | JPY |
| Collection of loans receivable inv cf IFRS | Prior1InterimDuration | 12000000 | JPY |
| Collection of loans receivable inv cf IFRS | InterimDuration | 9000000 | JPY |
| Payments for acquisition of subsidiaries inv cf IFRS | Prior1InterimDuration | -3238000000 | JPY |
| Payments for acquisition of subsidiaries inv cf IFRS | InterimDuration | -12143000000 | JPY |
| Proceeds from sale of investments accounted for using equity method inv cf IFRS | Prior1InterimDuration | － | JPY |
| Proceeds from sale of investments accounted for using equity method inv cf IFRS | InterimDuration | 285000000 | JPY |
| Payments for acquisition of businesses inv cf IFRS | Prior1InterimDuration | -38000000 | JPY |
| Payments for acquisition of businesses inv cf IFRS | InterimDuration | － | JPY |
| Other inv cf IFRS | Prior1InterimDuration | 93000000 | JPY |
| Other inv cf IFRS | InterimDuration | 342000000 | JPY |
| Net cash provided by used in investing activities IFRS | Prior1InterimDuration | -11325000000 | JPY |
| Net cash provided by used in investing activities IFRS | InterimDuration | -15522000000 | JPY |
| Dividends paid to owners of parent fin cf IFRS | Prior1InterimDuration | -14252000000 | JPY |
| Dividends paid to owners of parent fin cf IFRS | InterimDuration | -14250000000 | JPY |
| Dividends paid to non controlling interests fin cf IFRS | Prior1InterimDuration | -1904000000 | JPY |
| Dividends paid to non controlling interests fin cf IFRS | InterimDuration | -2856000000 | JPY |
| Capital contribution from non controlling interests fin cf IFRS | Prior1InterimDuration | － | JPY |
| Capital contribution from non controlling interests fin cf IFRS | InterimDuration | 22000000 | JPY |
| Proceeds from long term borrowings fin cf IFRS | Prior1InterimDuration | 6960000000 | JPY |
| Proceeds from long term borrowings fin cf IFRS | InterimDuration | 12325000000 | JPY |
| Repayments of borrowings fin cf IFRS | Prior1InterimDuration | -1407000000 | JPY |
| Repayments of borrowings fin cf IFRS | InterimDuration | -4068000000 | JPY |
| Payments for purchase of treasury shares fin cf IFRS | Prior1InterimDuration | -0 | JPY |
| Payments for purchase of treasury shares fin cf IFRS | InterimDuration | -2511000000 | JPY |
| Decrease increase in deposit paid for repurchase of treasury shares fin cf IFRS | Prior1InterimDuration | － | JPY |
| Decrease increase in deposit paid for repurchase of treasury shares fin cf IFRS | InterimDuration | -7486000000 | JPY |
| Proceeds from issuance of shares fin cf IFRS | Prior1InterimDuration | 0 | JPY |
| Proceeds from issuance of shares fin cf IFRS | InterimDuration | 5000000 | JPY |
| Repayments of lease obligations fin cf IFRS | Prior1InterimDuration | -2141000000 | JPY |
| Repayments of lease obligations fin cf IFRS | InterimDuration | -3377000000 | JPY |
| Other fin cf IFRS | Prior1InterimDuration | 104000000 | JPY |
| Other fin cf IFRS | InterimDuration | － | JPY |
| Net cash provided by used in financing activities IFRS | Prior1InterimDuration | -12639000000 | JPY |
| Net cash provided by used in financing activities IFRS | InterimDuration | -22196000000 | JPY |
| Effect of exchange rate changes on cash and cash equivalents IFRS | Prior1InterimDuration | -1180000000 | JPY |
| Effect of exchange rate changes on cash and cash equivalents IFRS | InterimDuration | 369000000 | JPY |
| Net increase decrease in cash and cash equivalents IFRS | Prior1InterimDuration | -1549000000 | JPY |
| Net increase decrease in cash and cash equivalents IFRS | InterimDuration | -1086000000 | JPY |
| Cash and cash equivalents IFRS | Prior2YearInstant | 149661000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |